iifl-logo

Chemfab Alkalis Ltd Board Meeting

768.25
(0.14%)
Jun 30, 2025|12:00:00 AM

Chemfab Alka. CORPORATE ACTIONS

01/07/2024calendar-icon
01/07/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting30 May 202530 May 2025
Dear Sir/Madam, We wish to inform you that Appointment of Mr. Satish Narain Jajoo as Additional Director(Independent) of the company for a period of five (5) Consecutive years with effect from 30th May 2025 subject to the approval of the shareholders in the ensuing Annual General Meeting
Board Meeting14 May 20257 May 2025
Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to consider and approve In line with the requirements of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company will be held on Wednesday 14th May 2025 at 12:00 PM (IST) to consider and approve inter-alia the following businesses: - i) Audited Standalone and Consolidated Financial Statements for the Quarter and Year Ended 31st March 2025. ii) Declaration of Dividend subject to the approval of Shareholders if any. Further pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015 the trading window for dealing in the shares of the Company has already commenced and the same shall remain closed for a period of 48 hours from the dissemination of results with the Stock Exchanges. Request you to kindly take the same on record as required under the provisions of the above captioned Regulation. Dear Sir/Madam, Please find the attached outcome of the Board Meetiing held on 14th May 2025. (As per BSE Announcement Dated on 14/05/2025)
Board Meeting30 Jan 202524 Jan 2025
Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve the unaudited financial results for the quarter ended 31st December 2024 and allotment of shares under the ESOP scheme. Outcome of the Board Meeting (As Per BSE Announcement Dated on 30/01/2025)
Board Meeting4 Nov 202425 Oct 2024
Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2024 inter alia to consider and approve i. Unaudited Financial Results for the quarter ended 30th September 2024. ii. Allotment of shares under ESOP scheme. Outcome of the Board Meeting (As Per BSE Announcement dated on 04.11.2024)
Board Meeting25 Sep 202425 Sep 2024
Outcome of the Board Meeting
Board Meeting8 Aug 202426 Jul 2024
Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve the unaudited financial results for the quarter ended 30th June 2024 and allotment of shares under the ESOP scheme for the employees. Outcome of the Board Meeting (As Per BSE Announcement dated on 08.08.2024)

Chemfab Alka.: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.